SCHEMBL17970102

SCHEMBL17970102

CC(C)(C)OC(=O)N1C[C@H](N)CC[C@H]1C(=O)ON1C(=O)CCC1=O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.34
▸ POLB P06746 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ CHRM2 P08172 1/20 0.33
▸ CHRM1 P11229 1/20 0.33
▸ CHRM3 P20309 1/20 0.33
▸ EPHX2 P34913 1/20 0.33
▸ ELANE P08246 1/20 0.33
▸ DDB1 Q16531 1/20 0.32
▸ CRBN Q96SW2 1/20 0.32
▸ HSD17B10 Q99714 2/20 0.32
▸ KDM4E B2RXH2 2/20 0.32
▸ MAPT P10636 1/20 0.32
▸ THRB P10828 1/20 0.32
▸ ATM Q13315 2/20 0.32
▸ KLK7 P49862 1/20 0.32
▸ UCHL1 P09936 2/20 0.32
▸ HSD11B1 P28845 1/20 0.31
▸ NPC1 O15118 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26464083 0.82 CYP1A2 (0.47) CYP1A2POLBCYP3A4CYP2C19CHRM2
SCHEMBL26464450 0.82 CYP1A2 (0.47) CYP1A2POLBCYP3A4CYP2C19CHRM2
SCHEMBL26464715 0.82 CYP1A2 (0.47) CYP1A2POLBCYP3A4CYP2C19CHRM2
SCHEMBL26464816 0.82 CYP1A2 (0.47) CYP1A2POLBCYP3A4CYP2C19CHRM2
SCHEMBL26464539 0.82 CYP1A2 (0.47) CYP1A2POLBCYP3A4CYP2C19CHRM2
SCHEMBL9893215 0.81 HSD17B10 (0.50) EPHX2HSD17B10KDM4EKLK7UCHL1
SCHEMBL4959104 0.81 HSD17B10 (0.50) EPHX2HSD17B10KDM4EKLK7UCHL1
SCHEMBL357242 0.81 HSD17B10 (0.50) EPHX2HSD17B10KDM4EKLK7UCHL1
SCHEMBL3055656 0.80 MMP2 (0.48) CYP1A2POLBCYP3A4CYP2C19CHRM2
SCHEMBL22655184 0.80 MMP2 (0.48) CYP1A2POLBCYP3A4CYP2C19CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3050883-A1 PRODUCTION METHOD FOR DIAZABICYCLOOCTANE DERIVATIVE AND INTERMEDIARY BODY THEREOF Meiji Seika Pharma Co., Ltd. (JP) 2016-08-03 — — EP disclosed
Send feedback